1. Home
  2. TXMD vs MCVT Comparison

TXMD vs MCVT Comparison

Compare TXMD & MCVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TXMD
  • MCVT
  • Stock Information
  • Founded
  • TXMD 2008
  • MCVT 2007
  • Country
  • TXMD United States
  • MCVT United States
  • Employees
  • TXMD N/A
  • MCVT N/A
  • Industry
  • TXMD Biotechnology: Pharmaceutical Preparations
  • MCVT Finance Companies
  • Sector
  • TXMD Health Care
  • MCVT Finance
  • Exchange
  • TXMD Nasdaq
  • MCVT Nasdaq
  • Market Cap
  • TXMD 12.7M
  • MCVT 11.1M
  • IPO Year
  • TXMD N/A
  • MCVT N/A
  • Fundamental
  • Price
  • TXMD $1.17
  • MCVT $7.30
  • Analyst Decision
  • TXMD
  • MCVT
  • Analyst Count
  • TXMD 0
  • MCVT 0
  • Target Price
  • TXMD N/A
  • MCVT N/A
  • AVG Volume (30 Days)
  • TXMD 23.3K
  • MCVT 7.6M
  • Earning Date
  • TXMD 08-12-2025
  • MCVT 08-14-2025
  • Dividend Yield
  • TXMD N/A
  • MCVT N/A
  • EPS Growth
  • TXMD N/A
  • MCVT 619.34
  • EPS
  • TXMD N/A
  • MCVT 0.24
  • Revenue
  • TXMD $1,841,000.00
  • MCVT $3,305,884.00
  • Revenue This Year
  • TXMD $427.09
  • MCVT N/A
  • Revenue Next Year
  • TXMD N/A
  • MCVT N/A
  • P/E Ratio
  • TXMD N/A
  • MCVT $30.23
  • Revenue Growth
  • TXMD 53.55
  • MCVT 1.77
  • 52 Week Low
  • TXMD $0.70
  • MCVT $1.13
  • 52 Week High
  • TXMD $2.44
  • MCVT $8.66
  • Technical
  • Relative Strength Index (RSI)
  • TXMD 54.93
  • MCVT 73.49
  • Support Level
  • TXMD $1.06
  • MCVT $6.50
  • Resistance Level
  • TXMD $1.12
  • MCVT $8.66
  • Average True Range (ATR)
  • TXMD 0.04
  • MCVT 1.11
  • MACD
  • TXMD 0.01
  • MCVT 0.14
  • Stochastic Oscillator
  • TXMD 73.27
  • MCVT 68.81

About TXMD TherapeuticsMD Inc.

TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.

About MCVT Mill City Ventures III Ltd.

Mill City Ventures III Ltd is a non-bank lender and specialty finance company. The company is engaged in the business of providing short-term specialty finance solutions to private businesses, micro-and small-cap public companies, and high-net-worth individuals. The principal specialty finance solutions that the group provides are high-interest short-term lending arrangements. Typically, these lending arrangements involve obtaining collateral as security for the borrower's repayment of funds, or personal guarantees from the principals or affiliates of the borrower.

Share on Social Networks: